Ruth Bader Ginsburg Archives - Page 2 of 2

HIGH COURT WEIGHS DRUG COMPANIES’ GENERICS POLICY

By JESSE J. HOLLAND and LINDA A. JOHNSON FILE – In this Aug. 12, 2011 file photo, Jeremy Lazarus, president-elect of the American Medical Association (AMA) speaks in Portland, Oregon.…

Tagged: AbbVie Inc, Actavis Inc, American Medical Association, Anthony Kennedy, Antonin Scalia, Business, Corporate lawsuits, Corporate legal affairs, Corporate news, Courts, Crime, Drug-related crime, Elena Kagan, Federal Trade Commission, General news, Government and politics, Health & Wellness, Health care costs, Health care industry, Health issues, Industries, Intellectual property, Judiciary, Law and order, Lawsuits, Legal proceedings, Legal settlements, National courts, National governments, North America, Ophir Resources Co, Patents, Pfizer Inc, Pharmaceutical manufacturing, Prescription drug costs, Professional organizations, Ruth Bader Ginsburg, Samuel Alito, Social affairs, Social groups and organizations, Sonia Sotomayor, Supreme Court of the United States, Supreme courts, Technology, United States, United States government, United States Supreme Court decisions

Ruth Bader Ginsburg

HIGH COURT WEIGHS DRUG COMPANIES’ GENERICS POLICY